Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX in Female Participants with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Go Back to All Clinical Trials

Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX in Female Participants with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Brief description of study

The purpose of this study is to investigate the safety (what side effects the study treatment may have) and effectiveness (how well the study treatment works to relieve symptoms) of BOTOX when injected into the bladder of adult females for the treatment of interstitial cystitis / bladder pain syndrome.

The study drug has been approved by the US Food and Drug Administration, to treat several specific medical conditions including other bladder conditions but has not yet been approved to treat Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). Therefore, the use of the study drug is considered investigational (experimental) for the purposes of this study.

Clinical Study Identifier: s22-00322

ClinicalTrials.gov Identifier: NCT05141006

Principal Investigator: Benjamin M. Brucker.

Other Investigator: Lauren E. Stewart.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies